| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.386.261 | 3.616.045 | 4.124.416 | 4.691.009 | 5.428.838 | 6.089.245 | 6.854.590 | 8.249.447 | 9.491.245 | 10.990.254 |
| Total Income - EUR | 3.413.137 | 3.646.979 | 4.180.437 | 4.720.187 | 5.480.374 | 6.158.570 | 6.962.537 | 8.414.998 | 9.642.884 | 11.126.151 |
| Total Expenses - EUR | 3.019.650 | 3.217.388 | 3.723.939 | 4.292.121 | 4.975.526 | 5.564.869 | 6.147.307 | 7.408.905 | 8.499.028 | 9.890.669 |
| Gross Profit/Loss - EUR | 393.487 | 429.590 | 456.498 | 428.067 | 504.848 | 593.702 | 815.230 | 1.006.092 | 1.143.857 | 1.235.482 |
| Net Profit/Loss - EUR | 335.563 | 368.225 | 390.891 | 368.064 | 433.523 | 514.717 | 721.834 | 872.626 | 1.012.785 | 1.090.934 |
| Employees | 23 | 26 | 27 | 29 | 33 | 35 | 36 | 37 | 37 | 42 |
Check the financial reports for the company - Primapharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 221.804 | 210.382 | 224.121 | 195.835 | 236.932 | 256.544 | 231.858 | 240.501 | 235.512 | 582.577 |
| Current Assets | 1.410.030 | 1.590.556 | 1.612.022 | 1.857.203 | 2.276.013 | 2.332.262 | 2.812.559 | 3.186.342 | 3.968.359 | 4.378.189 |
| Inventories | 680.571 | 759.704 | 895.934 | 768.463 | 1.147.159 | 1.036.214 | 1.307.382 | 1.387.147 | 2.075.856 | 2.412.853 |
| Receivables | 229.738 | 122.027 | 273.288 | 434.121 | 388.687 | 568.222 | 613.583 | 867.441 | 1.083.191 | 770.762 |
| Cash | 499.720 | 708.825 | 442.800 | 654.619 | 740.168 | 727.826 | 891.594 | 931.754 | 809.312 | 1.194.574 |
| Shareholders Funds | 1.232.232 | 1.064.244 | 1.437.127 | 1.778.816 | 2.177.891 | 2.360.074 | 2.523.545 | 2.277.435 | 3.262.967 | 3.726.315 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 400.209 | 736.950 | 399.064 | 274.221 | 335.055 | 228.733 | 520.872 | 1.149.408 | 940.904 | 1.234.451 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Primapharm S.r.l.